期刊文献+

盐酸坦索罗辛缓释胶囊对输尿管硬镜治疗不同部位输尿管上段结石的价值研究 被引量:2

Clinical value of tamsulosin hydrochloride sustained release capsule in the treatment of upper ureteral calculi in different parts by ureteroscopy
下载PDF
导出
摘要 目的:探讨盐酸坦索罗辛缓释胶囊在输尿管硬镜治疗不同部位输尿管上段结石手术中的临床应用价值。方法:回顾性分析自2016年3月至2021年6月在我院接受输尿管硬镜治疗的输尿管上段结石的178例患者临床资料,按其术前是否口服盐酸坦索罗辛缓释胶囊分为用药组(93例)和对照组(85例),对比分析两组手术成功率、肾盏可见率、术中“抱镜”发生率。进而再将两组按照结石所处不同位置分为输尿管上段的上、中、下三个部位,再次对上述指标进行对比分析。结果:用药组的手术成功率和肾盏可见率明显高于对照组(P<0.01),而术中“抱镜”发生率低于对照组(P<0.05)。将输尿管上段结石以肾下极、腰4横突、骶髂关节上缘为界,进一步将上段输尿管分为上部、中部、下部,两组上部和下部结石的手术成功率、肾盏可见率、术中“抱镜”率无显著差异(P>0.05),但是中部结石两组之间差异显著,用药组的手术成功率、肾盏可见率均显著高于对照组(P<0.05),术中“抱镜”的发生率明显低于对照组(P<0.05)。结论:盐酸坦索罗辛缓释胶囊可以松弛输尿管平滑肌,增加输尿管上段结石行输尿管硬镜治疗的成功率,减少术中“抱镜”风险。尤其对于处在肾下极与腰4横突之间的结石优势明显。 Objective:To explore the clinical value of tamsulosin hydrochloride sustainedrelease capsule in the treatment of upper ureteral calculi in different parts by ureteroscopy.Methods:The clinical data of 178 patients with upper ureteral calculi treated by ureteroscopy in our hospital from March 2016 to June 2021 were analyzed retrospectively.According to whether tamsulosin hydrochloride sustainedrelease capsule was taken orally before operation,they were divided into drug group(n=93)and control group(n=85).The success rate of operation,the visible rate of renal calices and the incidence of intraoperative"holding ureteroscopy"were compared and analyzed between the two groups.Then the two groups were divided into upper,middle and lower parts of the upper ureter according to the different positions of the stones,and the above indexes were compared and analyzed again.Results:The success rate of operation and the visible rate of renal calices in the medication group were significantly higher than those in the control group(P<0.01),while the incidence of intraoperative"holding ureteroscopy"was lower than that in the control group(P<0.05).The upper ureteral calculi is bounded by the lower pole of the kidney,the transverse process of L4 and the upper edge of sacroiliac joint,and the ureters were divided into upper,middle and lower parts.For upper and lower parts of upper ureteral calculi,there was no significant difference in the success rate of operation,the visible rate of renal calices and the intraoperative"holding ureteroscopy"rate between the two groups(P>0.05).But for middle pats of upper ureteral calculi,there was differet results.The success rate of operation and the visible rate of renal calices in the medication group were significantly higher than those in the control group(P<0.05),and the incidence of intraoperative"holding ureteroscopy"was significantly lower than that in the control group(P<0.05).Conclusion:Tamsulosin hydrochloride sustainedrelease capsule can relax ureteral smooth muscle,increase the success rate of rigid ureteroscopy for upper ureteral calculi,and reduce the risk of"holding ureteroscopy"during operation.Especially for stones located between the lower pole of the kidney and the transverse process of L4.
作者 赵豫波 王毅 张川 贾卓敏 王希友 谢常亮 陈安龙 徐衍盛 金一鹏 Zhao Yubo;Wang Yi;Zhang Chuan;Jia Zhuomin;Wang Xiyou;Xie Changliang;Chen Anlong;Xu Yansheng;Jin Yipeng(Department of Urology,the Third Medical center of Chinese PLA General Hospital,Beijing 100039,China)
出处 《微创泌尿外科杂志》 2022年第6期381-385,共5页 Journal of Minimally Invasive Urology
关键词 坦索罗辛 输尿管结石 输尿管镜 tamsulosin ureteral calculi ureteroscopy
  • 相关文献

参考文献10

二级参考文献94

  • 1吕家驹,尉立京,张辉,丁森泰,丁克家.坦索罗辛和硝苯地平在输尿管下段结石辅助排石中作用的比较[J].中华泌尿外科杂志,2006,27(9):612-614. 被引量:88
  • 2丁森泰,吕家驹,叶章群.α受体阻滞剂在输尿管下段结石治疗中的研究[J].临床泌尿外科杂志,2007,22(5):394-396. 被引量:33
  • 3熊玮,王坤杰,王莉,王佳,魏强,李虹.坦索罗辛用于输尿管结石排石治疗随机对照试验的Meta分析[J].中国循证医学杂志,2007,7(7):506-515. 被引量:22
  • 4Autorino R, De Sio M, Damiano R, et al. The use of tamsulosin in the medical treatment of ureteral calculi : where do we stand[J]. Urol Res, 2005, 33: 460-464.
  • 5Sigala S, dellabella M, Milanese G, et al. Evidence for the presence of alphal adrenoceptor subtypes in the human ureter[ J]. Neurourol Urodyn ,2005, 24 : 142-148.
  • 6Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different alphal adrenergic blockers for distal ureteral stones[J]. Urol,2005, 173:2010-2012.
  • 7Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones[ J ]. Urol,2003 ,170 :2202-2205.
  • 8Tiselius HG. Epidemiology and medical management of stone disease. BJU Int,2003,91 ( 8 ) :758-767.
  • 9Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Uro1,1999,162(3 pt 1 ) : 688-691.
  • 10Hubner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol, 1993,24(2) :172-176.

共引文献74

同被引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部